Spinocerebellar Ataxia Type 3
📧 Sign up to get email alerts when something new happens for Spinocerebellar Ataxia Type 3.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Troriluzole in Adult Participants With Spinocerebellar Ataxia [Phase 3]
Phase 3 trial update for troriluzole in adults with spinocerebellar ataxia indicating ongoing status with results posted in 2025.
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia [Phase 2, Phase 3]
A clinical trial update for STRIDES investigating an investigational drug for Spinocerebellar Ataxia Type 3 has been terminated after Phase …
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Chinese Medicine WT for Spinocerebellar Ataxia Type 3 [Phase 2]
Phase 2 clinical trial update for a Chinese medicine treatment for spinocerebellar ataxia type 3 has completed recruitment.
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Machado-Joseph Disease in Israel
A clinical trial update concerning Machado-Joseph disease (Spinocerebellar Ataxia Type 3) in Israel; the current trial status is unknown.
-
CLINICAL_TRIALS research · 2016-11-22Clinical Trial Update: Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Disease [Phase 2]
Phase 2 clinical trial evaluating intravenous Cabaletta for safety, tolerability, and efficacy in Machado-Joseph disease (spinocerebellar at…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3 [Phase 2, Phase 3]
A Phase 2/3 trial update reports on the safety and efficacy of lithium carbonate in patients with Spinocerebellar Ataxia Type 3 (Machado-Jos…
-
CLINICAL_TRIALS withdrawal · 2012-08-17Clinical Trial Update: Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3 [Phase 2]
Phase 2 pilot trial of sodium phenylbutyrate for Spinocerebellar Ataxia Type 3 has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-06-18Clinical Trial Update: Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3 [Phase 2]
This Phase 2 clinical trial completed evaluating the safety and tolerability of varenicline (Chantix) in Spinocerebellar Ataxia Type 3.